Outcomes after autologous stem cell transplantation in relapsed or refractory Hodgkin disease: The Duke experience

被引：0
|
作者：
Kim, D. W. [1 ]
Misra, D. [1 ]
Clough, R. W. [1 ]
Long, G. D. [1 ]
Prosnitz, R. G. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8100
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Allogeneic stem cell transplantation in relapsed/refractory Hodgkin's lymphoma: the timing of relapse after autologous transplant and the refractoriness of disease do not impact the survival outcomes
    Spina, F.
    Dalto, S.
    De Philippis, C.
    Viviani, S.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S68 - S68
  • [32] Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents
    Sica, R. Alejandro
    Spinner, Michael A.
    Tamaresis, John S.
    Advani, Ranjana H.
    Johnston, Laura J.
    Lowsky, Robert
    Meyer, Everett H.
    Miklos, David B.
    Muffly, Lori S.
    Rezvani, Andrew R.
    Shizuru, Judith A.
    Weng, Wen-Kai
    Negrin, Robert S.
    Arai, Sally
    BLOOD, 2019, 134
  • [33] Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience
    Nachbaur, D
    Oberaigner, W
    Fritsch, E
    Nussbaumer, W
    Gastl, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (01) : 43 - 49
  • [34] Autologous Stem Cell Transplantation in Refractory Hodgkin Lymphoma
    Petrova, G. D.
    Melkova, K.
    Chernyavskaya, T.
    Gorbunova, N.
    Kostrykina, V.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S282 - S282
  • [35] Consolidation Therapy After Autologous Stem Cell Transplant in Relapsed/Refractory Hodgkin Lymphoma
    O'Brien, Susan
    Moskowitz, Craig H.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (09) : 662 - 664
  • [36] Role of allogeneic stem cell transplantation in relapsed or refractory Hodgkin's disease
    Sureda, A
    Schmitz, N
    ANNALS OF ONCOLOGY, 2002, 13 : 128 - 132
  • [37] Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma
    A P Rapoport
    C Guo
    A Badros
    R Hakimian
    G Akpek
    E Kiggundu
    B Meisenberg
    H Mannuel
    N Takebe
    R Fenton
    J Bolaños-Meade
    M Heyman
    I Gojo
    K Ruehle
    S Natt
    B Ratterree
    T Withers
    C Sarkodee-Adoo
    G L Phillips
    G Tricot
    Bone Marrow Transplantation, 2004, 34 : 883 - 890
  • [38] Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma
    Rapoport, AP
    Guo, C
    Badros, A
    Hakimian, R
    Akpek, G
    Kiggundu, E
    Meisenberg, B
    Mannuel, H
    Takebe, N
    Fenton, R
    Bolaños-Meade, J
    Heyman, M
    Gojo, I
    Ruehle, K
    Natt, S
    Ratterree, B
    Withers, T
    Sarkodee-Adoo, C
    Phillips, GL
    Tricot, G
    BONE MARROW TRANSPLANTATION, 2004, 34 (10) : 883 - 890
  • [39] Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
    Anna Sureda
    Marc André
    Peter Borchmann
    Maria G. da Silva
    Christian Gisselbrecht
    Theodoros P. Vassilakopoulos
    Pier Luigi Zinzani
    Jan Walewski
    BMC Cancer, 20
  • [40] Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents
    Spinner, Michael A.
    Sica, R. A.
    Tamaresis, John S.
    Lu, Ying
    Chang, Cheryl
    Lowsky, Robert
    Frank, Matthew J.
    Johnston, Laura J.
    Miklos, David B.
    Ly, Lori S. Muff
    Negrin, Robert S.
    Rezvani, Andrew R.
    Shiraz, Parveen
    Shizuru, Judith A.
    Weng, Wen -Kai
    Binkley, Michael S.
    Hoppe, Richard T.
    Advani, Ranjana H.
    Arai, Sally
    BLOOD, 2023, 141 (22) : 2727 - 2737
12345